Scientists Create First Crystal Structure of an Intermediate Particle in Virus Assembly
News Mar 23, 2009
The structure, described Nature, provides fresh insights into the elegant dance that viral proteins perform to create the infectious structure that causes all manner of misery and disease, say researchers. While the virus they studied, HK97, only infects bacteria, well-known viruses such as herpes and HIV are also known to assemble an "intermediary" structure before morphing into its final assault-proof, infectious form.
"The principles of this multi-stage protein coat assembly will likely be similar across all complex viruses," says the study's senior author, Scripps Research Professor John E. Johnson. "But this process has never been seen before at this resolution, and now we know that what we thought happens, doesn't."
That's important, Johnson says, because if scientists understand how a virus builds its protective coat, they may be able to medically target vulnerabilities in the first stage of that assembly. "We believe that without its final shell to protect it, an immature virus will be much more defenseless to antiviral agents," he says.
Knowing how viruses build these vessels to protect the naked viral DNA inside is also useful in the field of medical nanotechnology, he adds. "The immature coat has lots of holes in it through which we could load drugs, and then seal it in the mature form to produce a potent delivery system," Johnson says.
Johnson and his research team have long studied HK97, and had "solved" the structure of the virus's mature outer coat. It is made up of 72 protein rings—12 pentagons and 60 hexagons—locked together like the chain mail suits worn by knights. This coating forms the head of the virus, which is extremely small—thousands of times narrower than a human hair.
The thin viral armor offers protection and stability as well as freedom of movement, Johnson says. "This is a container that works very well."
But the researchers say they spent five "painful" years trying to produce a crystal structure of the intermediate particle they knew was assembled first. They had produced images using electron microscopy, but they weren't detailed enough to understand the molecular processes involved.
The scientists built the viral shells in a test tube. Genes that encode the 420 proteins that make up the coat were expressed in e coli bacteria, the normal host of the virus. These proteins spontaneously assemble and form the immature particles. In the presence of viral DNA and the enzymes that pump it into the particles, they instantly form a mature coat that engulfs the genes.
The study's first author, Ilya Gertsman, a researcher in Johnson's lab, kept trying to capture the crystal structure of the intermediate form of the virus, but it always quickly morphed into its final armored form, even without DNA present. Finally, working with collaborators from the University of Pittsburgh, Gertsman used a form of HK97 that was mutated in such a way that made it slow to mature.
What the researchers saw from the crystal structure "was so beautiful," Gertsman says. The proteins that made up the spherical, soccer ball-like form were flat in shape and pointed outward, like hands placed palm to palm in prayer. But the moment the structure "sensed" the presence of DNA it immediately changed shape. In essence, the fingers on the praying hands folded down together, fingers interspersed and grasping each other. "That's why the final protein coat is so stable. The proteins are all intertwined around each other," Johnson says. Previously it was thought that the proteins went through this motion as a nearly rigid unit. This study showed that the proteins significantly changed in structure during the transition. The researchers don't yet know if this structural change happens all at once, or if it moves like a wave around the sphere.
They hypothesize that domains that hang from each of the proteins that eventually form the viral coat drive the process of changing the structure. The tails interact with each other to distort the shape of the proteins, Johnson says. "As long as the tails are there, the process of change is reversible. When the tails are gone (removed by a viral enzyme), the structure becomes stable," he says. Researchers had thought these tails, which are scaffolding proteins, guided assembly of the particle "but we think they actually change the structure," Johnson says. "That offers us another target by which we may be able to interrupt assembly of the coat."
In addition to Johnson and Gertsman, co-authors of the study, "An unexpected twist in viral capsid maturation," also include Lu Gan, Kelly Lee, and Jeffrey A. Speir from Scripps Research, Miklos Guttman and Elizabeth A. Komives from the University of California, San Diego, and Robert L. Duda and Roger W. Hendrix from the University of Pittsburgh. See http://www.nature.com/nature/journal/vaop/ncurrent/abs/nature07686.html.
The work was supported by grants from the National Institutes of Health.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE